Manually prepared data is often too old to accurately represent
status. Readily proving you're on track can be an ongoing
challenge. What are the bottlenecks?
Standardized reports often lack the flexibility
required to address the diverse needs of your globally
dispersed and outsourced clinical research teams.
Risk-based challenges are escalating as clinical trials become
more global and complex, and as market pressures keep
rising for new therapies at an ever-increasing pace.
Sponsors often have multiple studies running concurrently
with several CROs, complicating oversight. Reconciling CROs data
with different reporting formats can make timely oversight difficult.